Renugadevi Swaminathan

Renugadevi Swaminathan practices at KU MedWest Ambulatory Surgery in Shawnee, Kansas.

Renugadevi Swaminathan's NPI, 1427588607, was assigned on June 19, 2017. Renugadevi Swaminathan holds Kansas license 04-50041.

Renugadevi Swaminathan's primary practice is KU MedWest Ambulatory Surgery, at 7405 Renner Road, Shawnee, KS 66217. The practice phone is (913) 588-8411.

Renugadevi Swaminathan's primary practice is KU MedWest Ambulatory Surgery in Shawnee, Kansas. Renugadevi Swaminathan is also affiliated with The University of Kansas Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Renugadevi Swaminathan to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Renugadevi Swaminathan practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Renugadevi Swaminathan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Renugadevi Swaminathan is licensed in Kansas.

CMS data shows 45 Medicare services from Renugadevi Swaminathan across 3 procedure codes in 2024, for 69 Medicare patients. Medicare paid $5,272 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Renugadevi Swaminathan in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Renugadevi Swaminathan's median patient age at 62, with 66% women.

In 2024, Renugadevi Swaminathan wrote 61 Medicare Part D claims for 49 patients. 75% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $365 in total drug cost. In 2021, CMS named 68 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Renugadevi Swaminathan for performance year 2024, reported through an alternative payment model (APM). Renugadevi Swaminathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Renugadevi Swaminathan as offering telehealth. CMS counts 137 procedures of colonoscopy by Renugadevi Swaminathan, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Renugadevi Swaminathan in 2021. Renugadevi Swaminathan's most frequent co-author is Sudha Pandit, MD.

CMS Open Payments shows 7 general payments to Renugadevi Swaminathan from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $233.